These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 23549776)

  • 1. Expanded prescribing: a comparison of the views of Australian hospital and community pharmacists.
    Hoti K; Hughes J; Sunderland B
    Int J Clin Pharm; 2013 Jun; 35(3):469-75. PubMed ID: 23549776
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Independent prescribing by pharmacists: a study of the awareness, views and attitudes of Scottish community pharmacists.
    George J; Pfleger D; McCaig D; Bond C; Stewart D
    Pharm World Sci; 2006 Apr; 28(2):45-53. PubMed ID: 16752193
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exploring pharmacy service users' support for and willingness to use community pharmacist prescribing services.
    Famiyeh IM; MacKeigan L; Thompson A; Kuluski K; McCarthy LM
    Res Social Adm Pharm; 2019 May; 15(5):575-583. PubMed ID: 30100199
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preparing hospital pharmacists to prescribe: stakeholders' views of postgraduate courses.
    Kamarudin G; Penm J; Chaar B; Moles R
    Int J Pharm Pract; 2013 Aug; 21(4):243-51. PubMed ID: 23418670
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacist Intentions to Prescribe Hormonal Contraception Following New Legislative Authority in California.
    Vu K; Rafie S; Grindlay K; Gutierrez H; Grossman D
    J Pharm Pract; 2019 Feb; 32(1):54-61. PubMed ID: 29096570
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Restructuring supervision and reconfiguration of skill mix in community pharmacy: Classification of perceived safety and risk.
    Bradley F; Willis SC; Noyce PR; Schafheutle EI
    Res Social Adm Pharm; 2016; 12(5):733-46. PubMed ID: 26642961
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An evaluation of Australian pharmacist's attitudes on expanding their prescribing role.
    Hoti K; Sunderland B; Hughes J; Parsons R
    Pharm World Sci; 2010 Oct; 32(5):610-21. PubMed ID: 20683674
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identifying the perceived training needs for Australian pharmacist prescribers.
    Hoti K; Hughes J; Sunderland B
    Int J Pharm Pract; 2014 Feb; 22(1):38-46. PubMed ID: 23419013
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Community pharmacists' role in benzodiazepine supply in Ireland: a questionnaire of pharmacists' views and experiences.
    Cadogan CA; Ryder SA
    Int J Pharm Pract; 2015 Dec; 23(6):415-22. PubMed ID: 25756294
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A national survey exploring oral healthcare service provision across Australian community pharmacies.
    Freeman CR; Abdullah N; Ford PJ; Taing MW
    BMJ Open; 2017 Sep; 7(9):e017940. PubMed ID: 28963314
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Self-reported clinical pharmacy service provision in Austria: an analysis of both the community and hospital pharmacy sector-a national study.
    Deibl S; Mueller D; Kirchdorfer K; Stemer G; Hoppel M; Weidmann AE
    Int J Clin Pharm; 2020 Aug; 42(4):1050-1060. PubMed ID: 32494989
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacist prescribing: a cross-sectional survey of the views of pharmacists in Nigeria.
    Auta A; Strickland-Hodge B; Maz J; David S
    Int J Pharm Pract; 2018 Apr; 26(2):111-119. PubMed ID: 28497878
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of risks associated with the prescribing and dispensing of oral anticancer medicines in Ireland.
    Hammond L; Marsden E; O'Hanlon N; King F; Henman MC; Keane C
    Int J Clin Pharm; 2012 Dec; 34(6):893-901. PubMed ID: 22961608
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Provision of community pharmacy services during COVID-19 pandemic: a cross sectional study of community pharmacists' experiences with preventative measures and sources of information.
    Hoti K; Jakupi A; Hetemi D; Raka D; Hughes J; Desselle S
    Int J Clin Pharm; 2020 Aug; 42(4):1197-1206. PubMed ID: 32524513
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacists' adoption into practice of newly reclassified medicines from diverse therapeutic areas in Scotland: a quantitative study of factors associated with decision-making.
    Paudyal V; Hansford D; Cunningham S; Stewart D
    Res Social Adm Pharm; 2014; 10(1):88-105. PubMed ID: 23665077
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exploring views of pharmacists on antibacterial prescribing: a Maltese perspective.
    Attard Pizzuto M; Camilleri L; Azzopardi LM; Serracino-Inglott A
    Int J Pharm Pract; 2019 Jun; 27(3):256-263. PubMed ID: 30761641
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An expanded prescribing role for pharmacists - an Australian perspective.
    Hoti K; Hughes J; Sunderland B
    Australas Med J; 2011; 4(4):236-42. PubMed ID: 23393515
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Perspectives of future pharmacists on the potential for development and implementation of pharmacist prescribing in Qatar.
    Diab MI; Ibrahim A; Abdallah O; El-Awaisi A; Zolezzi M; Ageeb RA; Elkhalifa WHI; Awaisu A
    Int J Clin Pharm; 2020 Feb; 42(1):110-123. PubMed ID: 31898166
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of community pharmacy-based services for type-2 diabetes in an Indonesian setting: pharmacist survey.
    Wibowo Y; Parsons R; Sunderland B; Hughes J
    Int J Clin Pharm; 2015 Oct; 37(5):873-82. PubMed ID: 25986291
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacist prescribing in Northern Ireland: a quantitative assessment.
    McCann L; Haughey S; Parsons C; Lloyd F; Crealey G; Gormley GJ; Hughes CM
    Int J Clin Pharm; 2011 Oct; 33(5):824-31. PubMed ID: 21830075
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.